Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease

scientific article

Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/ARCHNEUR.59.6.986
P698PubMed publication ID12056935
P5875ResearchGate publication ID11317067

P2093author name stringRichard B Dewey
Padraig E O'Suilleabhain
P433issue6
P921main subjectParkinson's diseaseQ11085
dopamineQ170304
P304page(s)986-989
P577publication date2002-06-01
P1433published inArchives of NeurologyQ15766672
P1476titleContributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease
P478volume59

Reverse relations

cites work (P2860)
Q38662579A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease
Q37807698Alcohol, toxins, and medications as a cause of sleep dysfunction
Q47914157Analgesic Use and Daytime Sleepiness in Residents With and Without Dementia in Residential Aged Care Facilities.
Q33795585Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol.
Q79794456Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers
Q46886108Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers
Q30492844Comparison of pramipexole with and without domperidone co-administration on alertness, autonomic, and endocrine functions in healthy volunteers
Q36771635Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study
Q36659079Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class
Q64786322Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease
Q37060398Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease
Q43053755Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson's Disease
Q38153751Effects of rotigotine on Parkinson's disease-related sleep disturbances
Q52583507Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management.
Q35603764Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management
Q36415820Excessive daytime sleepiness and unintended sleep in Parkinson's disease
Q37842431Excessive daytime sleepiness in patients with Parkinson's disease
Q64867863Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men
Q39247889Frailty Levels in Residential Aged Care Facilities Measured Using the Frailty Index and FRAIL-NH Scale
Q41512722Is excessive daytime sleepiness a separate manifestation in Parkinson's disease?
Q38663680Mood and neural correlates of excessive daytime sleepiness in Parkinson's disease
Q57493665Neuroimaging of Sleep Disturbances in Movement Disorders
Q52579210Non-Motor Symptoms of Parkinson's Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients.
Q42655947Sleep disturbances in Taiwanese patients with Parkinson's disease.
Q48632030Sleepiness and Unintended Sleep in Parkinson's Disease
Q36076655Sleepiness in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease
Q48485654Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease
Q36842189Update on the use of pramipexole in the treatment of Parkinson's disease
Q79151543[Sleep in neurodegenerative disorders]

Search more.